Mounjaro (tirzepatide) is delivering some of the strongest weight loss results of any injectable on the market — clinical trials show average losses of 20 to 22% of body weight over 72 weeks. But those results come with a price tag that stops most South Africans in their tracks the moment they call their pharmacy. This guide breaks down exactly what Mounjaro costs in South Africa in 2026, how it stacks up against Ozempic per rand spent, and the realistic options for making it more affordable.
Important: This article is for information only. Always consult a registered doctor or endocrinologist before starting any weight loss injectable. Mounjaro is a prescription medicine in South Africa.
What Is Mounjaro and Why Does It Cost More Than Ozempic?
Mounjaro contains tirzepatide, a dual GIP/GLP-1 receptor agonist. Ozempic and Wegovy contain semaglutide, which activates GLP-1 receptors only. The dual-action mechanism is why Mounjaro tends to produce greater weight loss than semaglutide in head-to-head studies, and it is also a key reason the drug carries a higher price point. Eli Lilly holds a strong patent position with no generic competition in sight for several years.
In South Africa, Mounjaro was approved by SAHPRA and entered the market as a branded prescription product. There is currently no generic or compounded tirzepatide available in SA. Unlike semaglutide, where compounded alternatives exist at R800 to R1,500 per month, Mounjaro patients have no lower-cost fallback option.
Mounjaro Price in South Africa 2026: Per Pen by Dose
Mounjaro is supplied as pre-filled auto-injector pens. Each pen contains four weekly doses, making one pen equivalent to one month of treatment. Prices below are single exit price (SEP) estimates based on available pharmacy data — actual retail prices may vary slightly.
| Dose | Use Case | Price Per Pen (ZAR) | Monthly Cost (ZAR) |
|---|---|---|---|
| 2.5 mg | Starting dose (4 weeks) | R2,800 – R3,200 | R2,800 – R3,200 |
| 5 mg | First maintenance dose | R3,000 – R3,500 | R3,000 – R3,500 |
| 7.5 mg | Mid-range maintenance | R3,200 – R3,800 | R3,200 – R3,800 |
| 10 mg | Higher maintenance | R3,500 – R4,000 | R3,500 – R4,000 |
| 12.5 mg | Near-maximum dose | R3,800 – R4,300 | R3,800 – R4,300 |
| 15 mg | Maximum dose | R4,000 – R4,600 | R4,000 – R4,600 |
At the maintenance doses most weight-loss patients reach (7.5 mg to 12.5 mg), budget R3,200 to R4,300 per month as a realistic estimate. Over a full year that is R38,400 to R51,600 before any medical aid contribution.
Mounjaro vs Ozempic: Side-by-Side Cost Comparison
Both drugs are used for weight loss in South Africa. Ozempic is licensed for type 2 diabetes; Mounjaro has dual approval in some markets. Here is how they compare on cost and effectiveness:
| Factor | Mounjaro (Tirzepatide) | Ozempic (Semaglutide) |
|---|---|---|
| Mechanism | Dual GIP + GLP-1 | GLP-1 only |
| Monthly cost (ZAR) | R2,800 – R4,600 | R1,800 – R3,500 |
| Generic available in SA | No | Yes (compounded, R800–R1,500) |
| Average weight loss (72 weeks) | ~20–22% body weight | ~15–17% body weight |
| SAHPRA approved | Yes | Yes |
| Medical aid likelihood | Low to moderate (diabetes diagnosis) | Low to moderate (diabetes diagnosis) |
| Injection frequency | Once weekly | Once weekly |
| SA supply availability | Improving but patchy | More established |
| Est. cost per 1% weight lost/month | R170–R210 | R120–R210 |
The cost-per-percentage-of-weight-lost narrows the gap when you factor in Mounjaro's superior efficacy. If you achieve 22% weight loss on Mounjaro versus 15% on Ozempic, you may reach your goal weight faster — fewer months of treatment overall. That said, Ozempic's compounded generic option is a major financial advantage that Mounjaro cannot currently match.
Does Medical Aid Cover Mounjaro in South Africa?
Same frustrating answer as Ozempic: it depends on your diagnosis, your scheme, and your option.
When Medical Aid Is More Likely to Contribute
- You have a confirmed type 2 diabetes diagnosis
- Mounjaro is prescribed for glycaemic control, not weight management alone
- Your scheme covers it as a chronic medication benefit or PMB
- Your specialist provides a clinical motivation after trialling cheaper oral agents first
When Medical Aid Will Not Pay
- The prescription is for weight loss or obesity management only
- Your option's formulary excludes newer injectables
- You are on a hospital plan or basic option with limited chronic cover
- You have not completed the prior-authorisation process
Discovery Health, Bonitas, Momentum, Medshield, and Bestmed all handle GLP-1 injectables differently. Call your scheme's clinical team directly — not the general call centre. Ask specifically whether tirzepatide (the INN for Mounjaro) is covered under your chronic benefit and what the prior-authorisation requirements are. Some schemes require HbA1c above a threshold and evidence of prior oral diabetes medication failure before authorising any injectable.
Where to Buy Mounjaro in South Africa
Mounjaro is a Schedule 4 prescription medicine. You need a valid prescription from a registered medical practitioner.
Major Pharmacy Chains
- Dis-Chem — stocks Mounjaro at most larger branches; call ahead to confirm your dose is available before travelling
- Clicks — available at select branches; availability varies by province
- Independent pharmacies — some stock it, occasionally at a lower mark-up; worth phoning around
Private Weight Loss Clinics
Several private medical weight loss programmes in Johannesburg, Cape Town, Pretoria, and Durban prescribe Mounjaro as part of structured packages. These typically include doctor consultations, dietary coaching, and blood work monitoring. Expect R4,500 to R7,000 per month for a full programme including the medication.
Telehealth Services
SA-based telehealth providers can issue Mounjaro prescriptions after a video consultation, with the script dispensed through a partner pharmacy. Costs are generally similar to in-person pharmacy pricing, though consultation fees vary.
Caution: Do not purchase Mounjaro from unverified online sellers or social media listings. Counterfeit and mislabelled GLP-1 products circulate in SA's grey market. Read our guide on spotting fake GLP-1 injectables before buying from any unverified source.
The Long-Term Cost Reality
The most important cost factor most people underestimate is duration. Mounjaro is not a short course. Clinical data consistently shows that when patients stop tirzepatide, most of the lost weight returns within 12 months. This means:
- Mounjaro is effectively a long-term or lifelong treatment for obesity maintenance
- A 3 to 6 month trial will cost R8,400 to R27,600 and may not be enough time to reach full results
- Realistic budget planning should assume at least 12 to 18 months of treatment, followed by a discussion with your doctor about maintenance options
Researchers are investigating lower-dose maintenance regimens that reduce cost while preserving most of the weight loss. No standard maintenance protocol has been approved for SA use yet, but this is an active area of clinical research.
Ways to Reduce the Cost of Mounjaro
1. Use the Single Exit Price as Your Benchmark
SAHPRA regulates the maximum price pharmacies can charge for scheduled medicines. Ask for the SEP (single exit price) for your dose. Some pharmacies mark up above this — you can push back.
2. Sort Medical Aid Before Your First Script
If you have type 2 diabetes, get prior authorisation in place before filling your first prescription. Retrospective claims are rarely approved. Your endocrinologist should be familiar with the motivation process for each major scheme.
3. Consider Starting on Ozempic
If cost is a serious constraint, some doctors start patients on Ozempic (semaglutide), which has more established medical aid pathways and compounded generic options at R800 to R1,500 per month. If results plateau after 6 to 12 months, stepping up to Mounjaro is a reasonable clinical conversation. See our full Ozempic cost breakdown for the numbers.
4. Look at Clinic Group Packages
Some weight loss clinics in Gauteng and the Western Cape buy medication in bulk and pass on partial savings. Clinic packages also bundle consultations and monitoring you would otherwise pay for separately.
5. Track Your Results — and Stop If It Is Not Working
If you are not losing at least 5% of body weight after 12 to 16 weeks on an adequate dose, discuss with your doctor whether to continue. Some people respond better to semaglutide; others to tirzepatide. Continuing an expensive treatment that is not working costs money without benefit.
Full Weight Loss Injectable Cost Comparison (SA 2026)
| Drug | Active Ingredient | Monthly Cost (ZAR) | Generic Option | Avg Weight Loss |
|---|---|---|---|---|
| Mounjaro | Tirzepatide | R2,800 – R4,600 | Not available | 20–22% |
| Wegovy | Semaglutide 2.4 mg | R3,500 – R5,000 | Not available | 15–17% |
| Ozempic | Semaglutide 0.5–2 mg | R1,800 – R3,500 | Not officially | 15–17% |
| Saxenda | Liraglutide | R2,000 – R3,000 | No | 8–10% |
| Compounded semaglutide | Semaglutide (compounded) | R800 – R1,500 | This IS the generic | Variable |
Is Mounjaro Worth the Extra Cost Over Ozempic?
No single answer — it depends on your starting weight, your individual drug response, your budget, and your goals.
Mounjaro makes more sense if:
- You have a larger amount of weight to lose and need maximum efficacy
- You have type 2 diabetes and your endocrinologist recommends it for both glycaemic control and weight benefit
- You tried Ozempic and found results insufficient after 6 or more months
- Your medical aid will cover it
Ozempic (or compounded semaglutide) makes more sense if:
- Cost is the primary constraint
- You want to trial a GLP-1 injectable before committing to higher monthly spend
- Mounjaro is unavailable or hard to source in your area
- Your doctor has had better clinical results with semaglutide for your patient profile
Read more in our full Mounjaro weight loss guide and our semaglutide vs tirzepatide comparison.
Bottom Line
Mounjaro costs R2,800 to R4,600 per month in South Africa in 2026, making it the most expensive injectable weight loss option available per pen — but also the most effective per clinical data. Medical aid cover is possible for type 2 diabetes patients who meet authorisation criteria; for weight loss alone you are almost certainly paying out of pocket. No compounded or generic tirzepatide exists in SA, which removes the main budget option available to semaglutide users. Go in with a realistic budget for at least 12 months of treatment, verify your medical aid position before starting, and consult a doctor who specialises in obesity medicine to make the right call for your situation.
This article is informational only. All prices are estimates based on available pharmacy data and are subject to change. Consult a licensed South African medical practitioner before starting any prescription weight loss treatment.